Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

Automated Sample and Liquid Handling Platforms Suited for All Lab Sizes

By BiotechDaily International staff writers
Posted on 08 Jul 2014
Tecan Fluent laboratory automation solution
Automated Sample and Liquid Handling Platform (Photo courtesy of TECAN GROUP LTD.)
Biotech and other life scientists who work with cell-based assays now have available a new line of advanced automated sample and liquid handling platforms.

Tecan (Männedorf, Switzerland) has introduced the Fluent laboratory automation solution, the latest addition to its laboratory automation portfolio.

The Fluent system is available in three sizes—offering deck capacities from 30 to 72 microplates—to suit the throughput requirements of almost any laboratory. The instrument boasts a built-in touchscreen interface that guides users through every task, making even the most sophisticated cell-based assays easy to run. Fluent’s three, task-specific robotic arms work in parallel for faster processing, and offer automated lid handling to maintain sterility and minimize evaporation.

The Fluent platform was designed for integration with a variety of cell biology devices. This allows the user to control every step of the workflow, including storage, transfer, manipulation, and measurement of cellular samples on a single instrument.

The Tecan HydroSpeed plate washer features extra-gentle wash settings that can be adjusted to suit specific cells, microplates, and applications, ensuring reproducible results even with weakly adherent cells.

“Today’s research landscape looks different from yesterday’s, with customers wanting systems that are faster, more versatile, and more cost efficient,” said Dr. Stefan Traeger, head of life sciences business at Tecan. “The Fluent laboratory automation solution has initially been developed to address the needs of cell biology laboratories as they move towards greater miniaturization and higher throughput assays, and our test sites and assay partners have been impressed by its speed and capabilities for automating even complex cell-based assays.”

Related Links:


Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services

Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?



view channel
Image: A new catalyst that improved the sensitivity of the standard PSA ELISA test by about 110-fold was made of palladium nanocubes coated with iridium (Photo courtesy of Dr. Xiaohu Xia, Michigan Technological University).

Peroxidase Mimic Outperforms Natural Horseradish Peroxidase in ELISA Test

A test-of-concept study demonstrated that a synthetic catalyst that mimics the action of horseradish peroxidase (HRP) could increase the sensitivity of a colorimetric enzyme-linked immunosorbent assay... Read more

Drug Discovery

view channel
Image: Endoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places (Photo courtesy of Wikimedia Commons).

Orally Delivered Curcumin-Loaded Microparticles Effectively Treat Mouse Model of Ulcerative Colitis

Microparticles (MPs) loaded with the efficient anti-inflammatory agent curcumin were found to effectively treat a mouse model of ulcerative colitis. Ulcerative colitis is a chronic relapsing disease... Read more


view channel

Collaboration Agreement to Boost Discovery of Fully Human Antibodies for Therapeutic Use

The discovery of fully human antibodies for therapeutic use will be boosted by a recently announced collaboration between a major university research center and a dynamic biopharmaceutical development company. Regeneron Pharmaceuticals, Inc. (Tarrytown, New York, USA) and The Experimental Therapeutics Institute (ETI)... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.